In order to access this content you must be logged in and have a subscription to PL Intelligence.

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Protein Design to buy back Zenapax rights from Roche for $80 million
Roche and Protein Design Labs to Jointly Develop Zenapax® for Asthma
Oxford Biomedica, Protein Design Labs in drug partnership
ARIUS Research and Protein Design Labs sign agreement for expanded collaboration
Roche renal transplant drug Zenapax approved
ICOS to manufacture clinical candidate for Protein Design Labs
Protein Design Labs announces antibody research agreement with Fujisawa
Protein Design Labs announces clinical trial of SMART 1D10 antibody
Protein Design Labs and Celltech Chiroscience enter patent agreement
Protein Design Labs announces Phase III trial of SMART M195 antibody